Walter C. Low
Affiliations: | Neurourgery | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
Stem cellsGoogle:
"Walter Low"Mean distance: 15266.6
Children
Sign in to add traineeWilliam F. Kaemmerer | grad student | 2001 | UMN |
Marcus A. Westerman | grad student | 2001 | UMN |
Xilma R. Ortiz-Gonzalez | grad student | 2004 | UMN |
Terence C. Burns | grad student | 2007 | UMN |
Brian M. Andersen | grad student | 2013 | UMN |
Laura L. Hocum Stone | grad student | 2014 | UMN |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Jiang Y, Jahagirdar BN, Reinhardt RL, et al. (2024) Retraction Note: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature |
Walsh P, Truong V, Nayak S, et al. (2020) Accelerated Differentiation of Human Pluripotent Stem Cells into Neural Lineages via an Early Intermediate Ectoderm Population. Stem Cells (Dayton, Ohio) |
Crane AT, Aravalli RN, Asakura A, et al. (2019) Interspecies Organogenesis for Human Transplantation. Cell Transplantation. 963689719845351 |
Belur L, Tran TA, Pedersen KM, et al. (2016) 369. Therapeutic Effectiveness of AAV-Mediated Iduronidase Delivery to the CNS Following Intravenous Administration in a Murine Model of Mucopolysaccharidosis Type I Molecular Therapy. 24: S148 |
Laoharawee K, Podetz-Petersen KM, Kitto K, et al. (2016) 86. AAV9 Mediated Correction of Iduronate-2-Sulfatase Deficiency in the Central Nervous System to Prevent the Onset of Neurologic Deficits in a Murine Model of Mucopolysaccharidosis Type II Molecular Therapy. 24: S38 |
Belur L, Buckvold M, Podetz-Pedersen KM, et al. (2016) 25. Intranasal Gene Delivery of AAV Iduronidase: An Effective and Non-Invasive Approach for Treatmentof CNS Disease in a Murine Model of MPS Type I Molecular Therapy. 24: S12 |
Belur L, Buckvold M, Podetz-Pedersen K, et al. (2015) 706. Non-Invasive Intranasal Administration of AAV9-Iduronidase Prevents Emergence of Neurologic Disease and Neurocognitive Dysfunction in a Murine Model of Mucopolysaccharidosis Type I Molecular Therapy. 23: S281 |
Olin MR, Low W, McKenna DH, et al. (2014) Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response. Journal For Immunotherapy of Cancer. 2: 4 |
Tsimafeyeu I, Zaveleva E, Stepanova E, et al. (2013) OM-RCA-01, a novel humanized monoclonal antibody targeting fibroblast growth factor receptor 1, in renal cell carcinoma model Investigational New Drugs. 31: 1436-1443 |
Lo Nigro A, Geraerts M, Notelaers T, et al. (2012) MAPC culture conditions support the derivation of cells with nascent hypoblast features from bone marrow and blastocysts. Journal of Molecular Cell Biology. 4: 423-6 |